Whitney & Co’s Teladoc Health TDOC Stock Holding History

Whitney & Co’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-39	Closed	-$3K	–	419
2018 Q3	$3K	Buy	+39	New	+$2.78K	﹤0.01%	439

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Whitney & Co's TDOC Position: Q4 2018 in Review

Whitney & Co sold out of Teladoc Health (TDOC) in Q4 2018, closing a stake of 39 shares — an estimated $3K sold.

Whitney & Co first reported a position in TDOC in Q3 2018 and held it in 1 quarter. The position peaked at $3K in Q3 2018. 326 funds tracked by Wall St. Rank hold TDOC as of Q4 2018.

Whitney & Co reported no remaining Teladoc Health position as of Q4 2018 after selling out during the quarter.
Whitney & Co sold 39 Teladoc Health shares in Q4 2018, an estimated $3K.
Whitney & Co first reported a position in Teladoc Health in Q3 2018 and held it in 1 quarter.
Whitney & Co's Teladoc Health position peaked at $3K in Q3 2018.
326 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2018.

Based on Whitney & Co's 13F filing for Q4 2018, filed 7 Feb 2019.